GPHL presented at GBA IP Trade Expo

2020-12-04 12:16:32 GPHL GPHL

The Guangdong-Hong Kong-Macao Greater Bay Area Intellectual Property (GBAIP) Trade Expo 2020 was held from October 28th to November 3rd in a way of online expo due to the COVID-19 pandemic. GPHL had started the set-up on October 26th in order to showcase 44 intellectual property (IP) exhibits, 3 core trademarks (GPHL, Baiyuanshan and Wanglaoji), 34 patents and 7 newly authorised products.

In the Group, there are 4 national IP demonstration companies and 11 national advantageous IP companies, winning 13 patent excellence awards at the WIPO-SIPO Award for Chinese Outstanding Patented Invention and Industrial Design.

GPHL web page from GBAIP

From 2015 to 2019, the Group and its subsidiaries have applied for patents for 257 new inventions and 47 new utility models, in which 166 new inventions and 20 utility models were granted. So far GPHL has 464 patented inventions (including 450 domestic patents and 14 foreign patents), 69 patented utility models, 1 national confidential prescription (Hua Tuo Restorative Pills), 2,591 domestically registered trademarks as well as 260 overseas registered trademarks. All are before their expiration dates.

In 2015, GPHL received 4 patent excellence awards in the WIPO-SIPO Award for Chinese Outstanding Patented Invention and Industrial Design, which was the first time that GPHL has won 4 patent excellence awards in one time in this national patent award.

Precious results show in 2017, GPHL also received 2 patent excellence awards in the WIPO-SIPO Award for Chinese Outstanding Patented Invention and Industrial Design.

In 2018 three patented inventions from GPHL’s Chenliji, Hanfang and Baiyunshan Pharmaceutical General Factory received patent excellence awards.

In 2019 three patented inventions from GPHL’s Wanglaoji, Baiyunshan and Mingxing received patent excellence awards.


GPHL’s flagship products

Authors: Monica & Michelle

Editors: Olivia & Jerry

NULL